ClinicalTrials.Veeva

Menu

Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients (FongiFoie)

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

Fungal Infection

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are frequent and serious in immunocompromised individuals and especially in organ transplant patients. There is little recent data in liver transplantation, especially on the incidence and risk factors of fungal infections

Enrollment

300 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Age: from birth

  • Subject with a liver transplant in one of the centers participating in the study

  • Invasive fungal infection with filamentous fungus between 2007-2021

  • Proven or probable infection with filamentous fungi according to EORTC/MSGERC criteria:

    • Invasive aspergillosis
    • Mucormycosis
    • Fusariosis
    • Scedosporiosis
    • Other infection with filamentous fungus
  • Subject or legal representative for minors, who has not expressed, after information, his opposition to the reuse of his data for scientific research purposes.

Exclusion Criteria

  • Subject or (legal representative for minors) who has expressed his opposition to participating in the study
  • Subject not with a liver transplant
  • Subject under guardianship, curatorship or legal protection

Trial contacts and locations

1

Loading...

Central trial contact

François DANION, MD; Saïd CHAYER, PhD, HDR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems